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Abstract
Background—Varicella vaccine is available in the private sector in China, with a single dose 
currently recommended for children aged ≥12 months. We investigated a varicella outbreak in a 
school in Beijing with high varicella vaccination coverage to describe the outbreak, examine risk 
factors for vaccine failure, and calculate vaccine effectiveness.
Methods—A varicella case was defined as an acute generalized maculopapular rash without 
other apparent cause in a student without prior varicella attending the elementary school during 
August 30–December 28, 2010. Varicella among vaccinated students (breakthrough varicella) was 
defined as varicella occurring >42 days after vaccination. Students’ vaccination status was verified 
with immunization records and clinical presentations were collected from health care practitioners.
Results—Of the 951 students, 934 (98%) had no prior varicella history. Among these students, 
916 had received 1 dose of varicella vaccine and 2 had received 2 doses (98% vaccination 
coverage) before the outbreak. A total of 87 cases occurred during the outbreak; most had 
breakthrough varicella (86/87, 99%) and mild disease (83/87, 95%). Age at vaccination (<15 
months vs.≥15 months) and time since vaccination before outbreak (<5 years vs. ≥5 years) were 
not associated with development of breakthrough varicella. Single-dose varicella vaccination was 
89% effective in preventing any varicella and 99% in preventing moderate/severe varicella.
Conclusion—Single-dose varicella vaccination is highly effective in reducing varicella 
incidence and mitigating disease severity, but not high enough to prevent outbreak. A two-dose 
program might help to prevent varicella outbreaks in Beijing.
Keywords
Varicella outbreak; Varicella vaccine effectiveness
☆The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the 
Centers for Disease Control and Prevention, U.S. Department of Health and Human Services.
*Corresponding author at: Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS A-34, Atlanta, GA 30333, USA. 
Tel.: +1 404 639 7655; fax: +1 404 417 0795. cwang1@cdc.gov (C. Wang). 
Conflict of interest statement: No conflicts of interest relevant to this article were reported.
HHS Public Access
Author manuscript
Vaccine. Author manuscript; available in PMC 2015 October 26.
Published in final edited form as:














Varicella (chickenpox) is a highly contagious disease caused by infection with varicella 
zoster virus (VZV), and is characterized by a generalized pruritic vesicular rash. Although 
varicella is usually self-limiting and resolves within a week, severe complications, including 
death, can occur [1].
Varicella vaccines are now widely available globally for prevention and control of varicella. 
In China, varicella vaccine first was licensed for use as single dose in 1998. The vaccine has 
been shown to be highly effective in preventing varicella disease [2]. Currently, the vaccine 
is available for private purchase but is not included in national or provincial routine 
immunization programs. To control school-based outbreaks, single-dose vaccination has 
been provided free of charge by Beijing government since 2006 to unvaccinated students in 
Beijing schools. The vaccine is offered immediately after an outbreak is detected, a strategy 
which in some settings has been demonstrated to be effective [3,4].
In September 2010, the Beijing Center for Disease Control and Prevention (CDC) was 
notified of an outbreak in an elementary school. Because almost all students in the school 
had received varicella vaccine before the outbreak, most cases were among vaccinated 
students. Beijing CDC investigated this outbreak to (1) describe its epidemiology, (2) 
delineate transmission patterns, (3) examine varicella vaccine effectiveness (VE), and (4) 
assess whether age at vaccination or time since vaccination were related to vaccine failure. 
This article summarizes findings from this investigation and discusses the implications for 
varicella outbreak control and vaccination policy in Beijing, China.
2. Methods
2.1. Outbreak setting
The outbreak occurred in a public elementary school for Grades 1 and 2 (hereafter referred 
to as “School A”) in Beijing. During the outbreak, School A had 951 students. The 3-story 
school building includes 22 classrooms, 11 for each grade, with 7–8 classrooms on each 
floor. Mixing of students occurred in the classrooms, hallways, play areas, on school buses, 
and at after-school activities (e.g., drawing, dancing, and martial arts groups).
2.2. Case definition and data collection
A case of varicella was defined as an acute generalized maculopapular rash without other 
apparent cause that occurred during August 30–December 28, 2010 in a student attending 
School A [5]. Varicella among vaccinated students (breakthrough varicella) was defined as a 
varicella-like rash that developed >42 days after vaccination [5]. We used reports from the 
school nurse and the infectious disease surveillance system of Beijing CDC to identify 
cases. Parents of all students attending School A received and returned a questionnaire to 
provide information on history of varicella before the outbreak, and, for students with 
disease during the outbreak, disease severity, complications, and sources of exposure. 
Varicella cases were categorized as mild (<50 lesions) and moderate/severe (≥50 lesions). 
The vaccination status of each student before the outbreak was obtained from school 
records.
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2.3. Outbreak control measures
Students with varicella were excluded from school until lesions crusted or faded. On 
September 13 and October 14, 2010, varicella vaccinations were provided free of charge to 
unvaccinated students without a history of varicella. After-school activities were suspended 
and the classrooms, indoor play area, and school buses were disinfected when the outbreak 
was detected.
2.4. Statistical analyses
Sociodemographic factors and vaccination status of cases vs. non-cases students were 
compared and tested with Pearson Chi-square test, Fisher exact test, or Student’s t-test as 
appropriate. Vaccination coverage at the start of the outbreak was calculated as the 
proportion of vaccinated students among those without a history of varicella. VE for all 
varicella disease and for moderate/ severe disease was calculated using the equation: (1 − 
attack rate among vaccinated students/attack rate among unvaccinated students without a 
history of varicella) × 100%. Because few students were unvaccinated and only 1 
unvaccinated student was infected, we used historical attack rates among unvaccinated 
children in a child care center in the United States [6] to calculate VE. We evaluated 
potential risk factors for breakthrough disease among single dose varicella vaccine 
recipients; specifically, age at vaccination and time since vaccination before outbreak were 
categorized as <15 months vs. ≥15 months and <5 years vs. ≥5 years, respectively, as used 
in prior reports [7,8]. All data were analyzed by using SAS V9.2 (SAS Institute, Cary, NC).
3. Results
3.1. Study population
Among the 951 students in School A, 17 who had a history of varicella before the outbreak 
were excluded for further analysis (Fig. 1). No staff or faculty developed varicella during the 
outbreak and all analyses were restricted to students. Among the 934 students without 
disease history, 16 were unvaccinated and 918 had received vaccine before the outbreak (2 
of these had received 2 doses). During the outbreak, 11 of the unvaccinated students 
received vaccine and were excluded from further analysis; three of them developed rash at 1, 
14, and 28 days after vaccination, respectively. Among the 923 students included in the 
study, the average age was 7.0 years (range: 5.9–8.6), 52.7% were male, and 50.6% were in 
Grade 1.Overall vaccination coverage at the start of the outbreak among students without a 
history of varicella was 98.3% (range by classroom, 93–100%). Vaccination coverage was 
marginally higher in Grade 2 than in Grade 1 (99.1% vs. 97.5%, P = 0.05). Among single-
dose recipients (n = 916), the average age at vaccination was 22 months and the average 
time since vaccination before the outbreak was 5.1 years.
3.2. Outbreak
The outbreak lasted approximately 4 months, from August 30 through December 28, 2010. 
Among the 923 students included in the study, there were 87 cases with 86 among 
vaccinated students and 1 in an unvaccinated student (Fig. 1). The overall attack rate was 
9.4%. Four peaks of cases occurred in this outbreak at intervals of approximately two 
weeks: October 11–15, October 24–29, November 7–15, and November 24–29 (Fig. 2). The 
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primary case was a previously vaccinated Grade 1 student who was exposed to a 
neighborhood playmate who had varicella. The student developed fever 1 week later on 
August 29 and rash with <50 lesions on August 30. He likely transmitted the disease to 3 
classmates and another student, all on the first floor of the school building. The first peak of 
cases (n = 18) clustered on the first and second floors, and with just one case in a third floor 
classroom. Thereafter, disease spread throughout the school building, with the following 3 
peaks of cases mainly clustered on the second and third floors, with sporadic cases occurring 
on the first floor. Among the 22 classrooms in School A, three Grade 1 and one Grade 2 
classrooms had attack rates higher than 20% (range: 22–23.8%), with 9–10 cases per class. 
Among the other classrooms, 2 had no cases, 7 had only 1 case, 7 had 2–5 cases, and the 
other 2 had 7 and 8 cases, respectively. Two of the 4 unvaccinated students who were not 
infected were in a class without any cases during this outbreak.
3.3. Case characteristics
Most cases had mild disease (83, 95.4%) and were vaccinated (86, 98.9%); and 52 (59.8%) 
had fever. All the moderate/severe cases (n = 4) were single-dose vaccine recipients from 
different classes of two grades. No cases developed complications or were hospitalized due 
to varicella. School exposure was the source of infection for all cases, with the exception of 
the primary case and one case with hospital exposure. Most cases were among students in 
Grade 1 (55, 63.2%), and the average age was 6.8 years (range: 6–8.2 years) (Table 1). 
Cases and non-cases did not differ in vaccination status (P = 0.63), gender (P = 0.24), or age 
(P = 0.10). Compared with noncases, cases were more likely to be in Grade 1 (63.2% vs. 
49.3%, P = 0.01) (Table 1).
3.4. Vaccine effectiveness and risk factors for breakthrough disease
Among the 916 students who had received a single dose of varicella vaccine before the 
outbreak, 86 developed breakthrough varicella, of whom 4 developed rash with ≥50 lesions; 
thus, the overall attack rate was 9.4% and the attack rate for moderate/severe disease was 
0.4% among these single-dose recipients. The attack rate was 20% among the 5 
unvaccinated students with the only case being mild. Using historical attack rates of any 
disease (88%) and moderate/severe disease (55%) among unvaccinated children in children 
care center [6],we calculated single-dose VE of 89.3% for preventing any varicella and 
99.3% for preventing moderate/severe varicella. In single-dose recipients, age at vaccination 
(<15 months vs. ≥15 months) and time since vaccination (<5 years vs. ≥5 years) were not 
associated with breakthrough varicella in this outbreak (P = 0.78 and 0.44, respectively) 
(Table 1).
4. Discussion
In our investigation of a varicella outbreak that lasted for 4 months in a Beijing elementary 
school where one-dose varicella vaccine coverage before the outbreak was nearly 100%, 
disease was introduced by a vaccinated student and occurred almost exclusively among 
vaccinated students exposed at school. This study confirms that children vaccinated with a 
single-dose of varicella vaccine may both contract and transmit varicella, and high single-
dose varicella vaccination coverage may not provide sufficiently high population immunity 
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to prevent outbreaks [10–13]. This study also demonstrates, as have others, that single-dose 
varicella vaccination is highly effective in preventing cases and mitigating the severity of 
breakthrough cases that occurs [9].
In the United States, the first county to implement a universal varicella vaccination program, 
a single-dose regimen led to dramatic declines in varicella incidence, near elimination of 
severe disease and reduced the number, size, and duration of outbreaks [10]. During the 
single-dose varicella vaccination era in the United States, attack rates in school settings with 
high and low varicella vaccination coverage differed dramatically, from 9% to 15% in 
schools with coverage levels higher than 95% to 55% in a school with vaccination coverage 
of just 45% [6,11–14]. In China, comparisons of areas with high varicella vaccination 
coverage to those with low coverage or no varicella vaccination also clearly demonstrate the 
impact of varicella vaccination on reducing attack rates during outbreaks. In the outbreak 
reported here, in which one-dose coverage was high, the attack rate was less than 10%, with 
no severe outcomes. Elsewhere in China, in kindergartens and elementary schools where 
vaccination coverage was very low, average attack rates of more than 50% have been 
reported during outbreaks [15–17]. Given the effectiveness of varicella vaccine in 
preventing varicella and severe outcomes, hundreds of cases, and perhaps some 
complications and hospitalizations, likely were prevented among students in School A due 
to single-dose varicella vaccination. High vaccination coverage also provides indirect 
protection to unvaccinated students; among the 4 students who were not vaccinated before 
or during the outbreak and who attended school throughout the outbreak, 2 sat in a 
classroom where no infections occurred, and they did not become infected. The experience 
from this outbreak provides further evidence that varicella vaccine is the most effective tool 
for preventing and controlling varicella infection and mitigating disease severity and severe 
complications.
However, single-dose varicella vaccine effectiveness, while high, does not provide high 
enough population immunity to interrupt endemic disease transmission and prevent 
outbreaks completely. For this reason, the United States changed from a routine 1-dose 
varicella vaccination program for children to a universal 2-dose program in 2006 [18], in 
that the 2-dose varicella vaccination was 70% more effectively in preventing breakthrough 
disease than single-dose vaccination [19]. One goal of this revised policy was to prevent 
varicella outbreaks that continued to occur despite high single-dose vaccination coverage 
[18] Since implementation of the universal 2-dose program in the United States, further 
reductions have been seen in both varicella disease burden [20,21], and the number of 
outbreaks [21]. More data are needed to assess the effectiveness of 2-dose varicella 
vaccination and its impact on the rate of breakthrough disease and reduction in number of 
outbreaks.
Post-exposure varicella vaccination can be effective in preventing illness or modifying 
varicella severity if administered within five days after exposure [18]. Thus timely 
vaccination when an outbreak is detected may help to reduce size and duration of varicella 
outbreak, which may be resulted from the combined protective effect from pre- and post-
exposure vaccination since not all students were exposed at the start of an outbreak. 
However, with the increase in the number of schools with high single-dose varicella 
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vaccination coverage among their students and fewer students eligible to receive their first 
dose of vaccine during outbreak response efforts, Beijing may need to consider other options 
to further reduce varicella spread in school populations. Prior to implementation of the 
universal two-dose varicella vaccination program in the United States, a second dose of 
varicella vaccine was recommended for outbreak control in settings with high one-dose 
varicella vaccination coverage [22].
Policy makers from other countries are likely to consider the U.S. experience with one- and 
two-dose routine varicella vaccination programs in addition to disease burden, vaccine cost, 
and vaccine availability in deciding whether to implement one-dose or 2-dose varicella 
vaccination programs. In addition to public health and socioeconomic considerations, the 
World Health Organization emphasizes that varicella vaccination programs should only be 
implemented if high vaccination coverage (85–90%) can be maintained [23]. Sustained high 
coverage is essential to prevent an epidemiologic shift in disease incidence which may lead 
to more varicella among adolescents and adults, who are more prone to develop severe 
disease [24].
The current study has limitations. We relied on clinical diagnosis of cases and did not 
require laboratory confirmation. Although varicella is still a common disease in Beijing and 
clinical practitioners are very experienced in diagnosing varicella, misdiagnosis is possible 
because breakthrough varicella is often less severe. In addition, the mild clinical 
presentation of breakthrough varicella makes under-reporting likely in the absence of 
thorough case finding efforts, particularly in this setting in which most cases occurred in 
vaccinated students who had mild disease with few lesions [14]. The attack rates of 
unvaccinated children in U.S. school settings that we used to calculate VE may 
underestimate effectiveness since schools in Beijing may be more crowded and more 
favorable for facilitating varicella transmission. The lower household exposure due to the 
‘One Child’ policy and the possibility of higher community exposure for children in China 
than in the U.S. may lead under- or over-estimates of varicella VE in the current study as a 
result of our use of a historical attack rate. Unfortunately, there are no comparable published 
attack rates from China available to us. The small number of unvaccinated students (n = 5) 
and unvaccinated case (n = 1) also make it impossible to get a reliable VE estimate using the 
attack rate in the unvaccinated students from this school, and we had to resort to the 
historical attack rate among unvaccinated in school setting [6].
In summary, we found that one-dose varicella vaccination in Beijing, while effective for 
preventing varicella, and extremely effective for preventing severe disease, is not 
sufficiently high enough to prevent outbreaks in settings where exposure is intense. The 
single-dose free vaccination strategy becomes less effective for outbreak control in highly 
vaccinated settings. More aggressive measures, such as 2-dose regimen, may be an option to 
prevent varicella outbreaks, but policy changes will need to be based on consideration of 
disease burden, social impact, program cost, affordability, vaccine supply, and 
sustainability.
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Vaccination and varicella case status, varicella outbreak in School A, Beijing, 2010.
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Varicella cases by date of rash onset and vaccination status (n = 87), School A, Beijing, 
August 30–December 28, 2010.
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Table 1
Comparison of students with and without varicella during a varicella outbreak, School A, Beijing, 2010.
Students with varicella (n = 87) Students without varicella (n = 836) P value
Gender 0.24
  Male 51(10.5) 435(89.5)
  Female 36(8.2) 401(91.8)
Age in years before outbreak
  Mean (SD) 6.8 (0.6) 7.0 (0.7) 0.10
Vaccination status before outbreak 0.63
  Unvaccinated 1(20.0) 4(80.0)
  1-Dose 86(9.4) 830(90.6)
  2-Dose 0 (0.0) 2(100.0)
Grade 0.01
  1 55(11.8) 412(88.2)
  2 32(7.0) 424(93.0)
Age at vaccinationa 0.78
  <15 months 30(9.0) 302(91.0)
  ≥15 months 56(9.6) 528(90.4)
Time since vaccination before outbreaka 0.44
  <5 years 30(8.5) 325(91.5)
  ≥5 years 56(10.0) 505(90.0)
a
Single-dose varicella vaccine recipients only.
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